Risk of Cardiovascular Events and Pulmonary Hypertension Following Splenectomy - a Danish Population-based Cohort Study from 1996-2012

Overview

Journal Haematologica

Specialty Hematology

Date 2017 Jun 3

PMID 28572164

Citations 12

Authors

Marianne Rorholt

Waleed Ghanima

Dora Kormendine Farkas

Mette Norgaard

Affiliations

Soon will be listed here.

Abstract

Splenectomized patients are at increased risk of cardiovascular events, but it remains unclear whether this is due to lack of the spleen or due to the underlying disease leading to splenectomy. We aimed to assess the risk of myocardial infarction, pulmonary hypertension, and stroke following splenectomy. We identified patients splenectomized in Denmark between 1996 and 2012. We constructed two comparison cohorts: an age- and sex-matched general population cohort and a disease-matched cohort based on the splenectomy-related underlying disease. We computed 5-year cumulative incidences and adjusted hazard ratios of myocardial infarction, pulmonary hypertension, and stroke for the three cohorts. The study included 5,306 splenectomized patients, 53,060 members of the general population, and 11,651 disease-matched patients. During the 5-year follow-up, 1.3% of splenectomized patients had a myocardial infarction 1.8% of the population cohort. The adjusted hazard ratio for myocardial infarction in splenectomized patients the population cohort was 1.24 (95% confidence interval: 1.01-1.52). The 5-year cumulative incidence of pulmonary hypertension was 0.4% among splenectomized subjects and 0.2% in the population cohort [adjusted hazard ratio 3.25 (95% confidence interval: 1.93-5.45)], while that of stroke was 3.3% among splenectomized patients 2.6% in the population cohort [adjusted hazard ratio 2.04 (95% confidence interval: 1.78-2.35)]. When comparing splenectomized subjects with the disease-matched cohort, only stroke risk was elevated, with 5-year risks of 3.0% and 2.3%, respectively [adjusted hazard ratio 1.56 (95% confidence interval: 1.26-1.92)]. In conclusion, splenectomized patients were at increased risk of stroke. Additionally, we found that underlying splenectomy-related diseases explained the increased risk of myocardial infarction and pulmonary hypertension following splenectomy.

Citing Articles

The spleen in ischaemic heart disease.

Heusch G, Kleinbongard P Nat Rev Cardiol. 2025; .

PMID: 39743566 DOI: 10.1038/s41569-024-01114-x.

Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia.

Goshua G, Sinha P, Kunst N, Pischel L, Lee A, Cuker A Am J Hematol. 2022; 98(1):122-130.

PMID: 35147241 PMC: 9365880. DOI: 10.1002/ajh.26497.

Immune Thrombocytopenia: Are We Stuck in the Mud or Is There Light at the End of the Tunnel?.

Bussel J, Miltiadous O Clin Hematol Int. 2021; 1(4):173-179.

PMID: 34595428 PMC: 8432374. DOI: 10.2991/chi.d.190805.001.

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.

Audia S, Mahevas M, Nivet M, Ouandji S, Ciudad M, Bonnotte B Hemasphere. 2021; 5(6):e574.

PMID: 34095758 PMC: 8171374. DOI: 10.1097/HS9.0000000000000574.

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Cooper N, Altomare I, Thomas M, Nicolson P, Watson S, Markovtsov V Ther Adv Hematol. 2021; 12:20406207211010875.

PMID: 33995988 PMC: 8111531. DOI: 10.1177/20406207211010875.

References

Jais X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A . Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax. 2005; 60(12):1031-4. PMC: 1747270. DOI: 10.1136/thx.2004.038083. View

Yusuf H, Hooper W, Grosse S, Parker C, Boulet S, Ortel T . Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Thromb Res. 2014; 135(1):50-7. PMC: 4480419. DOI: 10.1016/j.thromres.2014.10.012. View

SCHILLING R . Spherocytosis, splenectomy, strokes, and heat attacks. Lancet. 1997; 350(9092):1677-8. DOI: 10.1016/s0140-6736(05)64276-6. View

Schmidt M, Schmidt S, Sandegaard J, Ehrenstein V, Pedersen L, Sorensen H . The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015; 7:449-90. PMC: 4655913. DOI: 10.2147/CLEP.S91125. View

SCHILLING R, Gangnon R, Traver M . Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost. 2008; 6(8):1289-95. DOI: 10.1111/j.1538-7836.2008.03024.x. View

Ramagopalan S, Wotton C, Handel A, Yeates D, Goldacre M . Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011; 9:1. PMC: 3025873. DOI: 10.1186/1741-7015-9-1. View

Cadili A, de Gara C . Complications of splenectomy. Am J Med. 2008; 121(5):371-5. DOI: 10.1016/j.amjmed.2008.02.014. View

Yong M, Thomsen R, Schoonen W, Farkas D, Riis A, Fryzek J . Mortality risk in splenectomised patients: a Danish population-based cohort study. Eur J Intern Med. 2010; 21(1):12-6. DOI: 10.1016/j.ejim.2009.10.003. View

Crary S, Buchanan G . Vascular complications after splenectomy for hematologic disorders. Blood. 2009; 114(14):2861-8. PMC: 2756197. DOI: 10.1182/blood-2009-04-210112. View

10.

Blann A, Lip G . Venous thromboembolism. BMJ. 2006; 332(7535):215-9. PMC: 1352055. DOI: 10.1136/bmj.332.7535.215. View

11.

Taher A, Ismaeel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz E . Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006; 96(4):488-91. View

12.

Kronborg C, Hallas J, Jacobsen I . Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens. 2010; 3(1):19-24.e2. DOI: 10.1016/j.jash.2008.08.001. View

13.

Glynn R, Rosner B . Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005; 162(10):975-82. DOI: 10.1093/aje/kwi309. View

14.

DeFrances C, Cullen K, Kozak L . National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2008; (165):1-209. View

15.

Hoeper M, Niedermeyer J, Hoffmeyer F, Flemming P, FABEL H . Pulmonary hypertension after splenectomy?. Ann Intern Med. 1999; 130(6):506-9. DOI: 10.7326/0003-4819-130-6-199903160-00014. View

16.

Di Sabatino A, Carsetti R, Corazza G . Post-splenectomy and hyposplenic states. Lancet. 2011; 378(9785):86-97. DOI: 10.1016/S0140-6736(10)61493-6. View

17.

Sorensen H, Sabroe S, Olsen J . A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996; 25(2):435-42. DOI: 10.1093/ije/25.2.435. View

18.

Peacock A . Pulmonary hypertension after splenectomy: a consequence of loss of the splenic filter or is there something more?. Thorax. 2005; 60(12):983-4. PMC: 1747269. DOI: 10.1136/thx.2005.043216. View

19.

Thomsen R, Schoonen W, Farkas D, Riis A, Fryzek J, Sorensen H . Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study. J Thromb Haemost. 2010; 8(6):1413-6. DOI: 10.1111/j.1538-7836.2010.03849.x. View

20.

Severinsen M, Engebjerg M, Farkas D, Jensen A, Norgaard M, Zhao S . Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2010; 152(3):360-2. DOI: 10.1111/j.1365-2141.2010.08418.x. View